Mariner’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-109,131
| Closed | -$11.1M | – | 3646 |
|
|
2025
Q4 | $11.1M | Buy |
109,131
+57,323
| +111% | +$4.6M | 0.01% | 662 |
|
|
2025
Q3 | $2.83M | Buy |
51,808
+12,854
| +33% | +$642K | ﹤0.01% | 1223 |
|
|
2025
Q2 | $2.07M | Buy |
38,954
+12,605
| +48% | +$640K | ﹤0.01% | 1317 |
|
|
2025
Q1 | $1.14M | Sell |
26,349
-398
| -1% | -$20.2K | ﹤0.01% | 1601 |
|
|
2024
Q4 | $1.5M | Sell |
26,747
-338
| -1% | -$21K | ﹤0.01% | 1379 |
|
|
2024
Q3 | $1.84M | Sell |
27,085
-4,501
| -14% | -$254K | ﹤0.01% | 1231 |
|
|
2024
Q2 | $1.33M | Sell |
31,586
-1,787
| -5% | -$98.3K | ﹤0.01% | 1331 |
|
|
2024
Q1 | $2.3M | Sell |
33,373
-2,369
| -7% | -$150K | ﹤0.01% | 1041 |
|
|
2023
Q4 | $2.64M | Sell |
35,742
-992
| -3% | -$65K | 0.01% | 935 |
|
|
2023
Q3 | $2.51M | Buy |
36,734
+4,611
| +14% | +$391K | 0.01% | 889 |
|
|
2023
Q2 | $3.02M | Buy |
32,123
+2,704
| +9% | +$211K | 0.01% | 823 |
|
|
2023
Q1 | $1.99M | Buy |
29,419
+287
| +1% | +$18.4K | 0.01% | 960 |
|
|
2022
Q4 | $1.44M | Sell |
29,132
-5,045
| -15% | -$206K | ﹤0.01% | 1068 |
|
|
2022
Q3 | $1.11M | Sell |
34,177
-671
| -2% | -$27.7K | ﹤0.01% | 1002 |
|
|
2022
Q2 | $1.37M | Buy |
34,848
+1,118
| +3% | +$59.8K | 0.01% | 817 |
|
|
2022
Q1 | $2.36M | Buy |
33,730
+68
| +0.2% | +$4.97K | 0.01% | 681 |
|
|
2021
Q4 | $2.62M | Sell |
33,662
-9,014
| -21% | -$796K | 0.01% | 593 |
|
|
2021
Q3 | $4.07M | Buy |
42,676
+16,537
| +63% | +$1.75M | 0.02% | 396 |
|
|
2021
Q2 | $3.25M | Buy |
26,139
+799
| +3% | +$95.4K | 0.02% | 392 |
|
|
2021
Q1 | $3.34M | Buy |
25,340
+13,208
| +109% | +$1.81M | 0.02% | 365 |
|
|
2020
Q4 | $1.61M | Buy |
12,132
+70
| +0.6% | +$8.46K | 0.01% | 470 |
|
|
2020
Q3 | $1.23M | Sell |
12,062
-1,483
| -11% | -$128K | 0.01% | 462 |
|
|
2020
Q2 | $1.18M | Buy |
+13,545
| New | +$1.08M | 0.01% | 464 |
|
|
2019
Q3 | – | Sell |
-5,723
| Closed | -$676K | – | 794 |
|
|
2019
Q2 | $676K | Buy |
5,723
+683
| +14% | +$68.8K | 0.01% | 624 |
|
|
2019
Q1 | $437K | Sell |
5,040
-456
| -8% | -$38.8K | 0.01% | 707 |
|
|
2018
Q4 | $347K | Buy |
+5,496
| New | +$377K | 0.01% | 647 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Mariner's EXAS Position: Q1 2026 in Review
Mariner sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 109,131 shares — an estimated $11.1M sold.
Mariner first reported a position in EXAS in Q4 2018 and held it in 26 quarters. The position peaked at $11.1M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Mariner reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Mariner sold 109,131 Exact Sciences shares in Q1 2026, an estimated $11.1M.
- Mariner first reported a position in Exact Sciences in Q4 2018 and held it in 26 quarters.
- Mariner's Exact Sciences position peaked at $11.1M in Q4 2025.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.